CVE-2025-5459 json
OS Command Injection
published 2025-06-26 16 mo ago modified 2026-09-04 2 mo ago also EUVD-2025-19173
- cvss
- 8.8
- version 3.1, NVD
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 1.1%
- EPSS 1.1% chance of exploitation in 30 days, percentile 65%
- public exploits
- 0
- none known
Summary
A user with specific node group editing permissions and a specially crafted class parameter could be used to execute commands as root on the primary host. It affects Puppet Enterprise versions 2018.1.8 through 2023.8.3 and 2025.3 and has been resolved in versions 2023.8.4 and 2025.4.0.
Patch / fix
- puppet puppet 2023.8.4, 2025.4.0
- puppet puppet_enterprise 2023.8.4, 2025.4.0
- puppet puppet_server 2023.8.4, 2025.4.0
CISA SSVC
- Exploitation
- none
- Automatable
- no
- Technical impact
- total
- Assessed
- 16 mo ago
Exploit prediction
1.10% chance of exploitation in the next 30 days, higher than 65% of all scored CVEs (FIRST EPSS, 2026-11-08).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| CNA | 4.0 | 8.6 | CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N |
| CNA | 4.0 | 8.6 | CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X |
| NVD | 3.1 | 8.8 | CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H |
Affected products
- Perforce Puppet Enterprise
Classification
- Weakness
-
- CWE-78 Improper Neutralization of Special Elements used in an OS Command
References
-
portal.perforce.com
/s/detail/a91PA000001SiDdYAK
third-party-advisory
- seclists.org /fulldisclosure/2026/Sep/9
Sources
- CVE List CVE-2025-5459
- NVD CVE-2025-5459
Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.
CPEs and fixed versions use Anchore's correction of NVD's data: Added CPE configurations because not yet analyzed by NVD.